Eton Pharmaceuticals (ETON) Total Non-Current Liabilities (2024 - 2025)
Historic Total Non-Current Liabilities for Eton Pharmaceuticals (ETON) over the last 3 years, with Q3 2025 value amounting to $76.2 million.
- Eton Pharmaceuticals' Total Non-Current Liabilities changed N/A to $76.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.2 million, marking a year-over-year change of. This contributed to the annual value of $49.9 million for FY2024, which is 20661.62% up from last year.
- According to the latest figures from Q3 2025, Eton Pharmaceuticals' Total Non-Current Liabilities is $76.2 million.
- Eton Pharmaceuticals' 5-year Total Non-Current Liabilities high stood at $76.2 million for Q3 2025, and its period low was $16.3 million during Q4 2023.
- Its 3-year average for Total Non-Current Liabilities is $53.7 million, with a median of $55.4 million in 2025.
- The largest annual percentage gain for Eton Pharmaceuticals' Total Non-Current Liabilities in the last 5 years was 20661.62% (2024), contrasted with its biggest fall of 20661.62% (2024).
- Quarter analysis of 3 years shows Eton Pharmaceuticals' Total Non-Current Liabilities stood at $16.3 million in 2023, then skyrocketed by 206.62% to $49.9 million in 2024, then soared by 52.8% to $76.2 million in 2025.
- Its Total Non-Current Liabilities stands at $76.2 million for Q3 2025, versus $70.8 million for Q2 2025 and $55.4 million for Q1 2025.